$ Value
$0
Shares
59,819
Price
$0
Filed
Jul 11
Insider
Name
Onyia Jude
Title
Chief Scientific Officer
CIK
0001894425
Roles
Transaction Details
Transaction Date
2025-07-09
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
35,268
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. | Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $130.00 to $131.45. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents option of which 1/4th of the shares underlying the option became vested and exercisable on November 29, 2022 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter.
Filing Info
Onyia Jude's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-20 | NBIX | G | $0 |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | F | $180K |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | F | $182K |
| 2026-02-13 | NBIX | A | $0 |
| 2026-02-13 | NBIX | F | $1.3M |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | M | $0 |
| 2026-02-13 | NBIX | A | $0 |
Other Insiders at NBIX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GORMAN KEVIN CHARLES | — | — | 2026-02-13 |
|
Lippoldt Darin
Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gano Kyle
Chief Executive Officer
|
— | — | 2026-02-13 |
|
BENEVICH ERIC
Chief Commercial Officer
|
— | — | 2026-02-13 |
|
ABERNETHY MATT
Chief Financial Officer
|
— | — | 2026-03-04 |
|
Cooke Julie
Chief Human Resources Officer
|
— | — | 2026-02-13 |
|
Keswani Sanjay Chandru
Chief Medical Officer
|
— | — | 2026-02-13 |
|
Onyia Jude
Chief Scientific Officer
|
— | — | 2026-02-20 |
|
Boyer David W.
Chief Corp. Affairs Officer
|
— | — | 2026-02-13 |
|
Delaet Ingrid
Chief Regulatory Officer
|
— | — | 2026-02-13 |